Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • Roe v. Wade Overturned
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • Roe v. Wade Overturned
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs. 

  • Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

  • Policy Analysis

    The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

  • Policy Analysis

    Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

Top Facts & Statistics

  • 1.5M

    women living with HIV become pregnant each year worldwide
  • $10.60

    the annual per-person cost in LMICs to meet the need for essential sexual and reproductive health services
  • 1 in 3

    pregnant women in the developing world living with HIV receive no antiretroviral medication

Resources

  • November 2014 Infographic

    Pourquoi investir dans la santé sexuelle et reproductive en Afrique subsaharienne?

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Infographic

    ¿Por qué invertir en salud sexual y reproductiva en América Latina y el Caribe?

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Infographic

    Why invest in sexual and reproductive health in Asia?

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Infographic

    Why invest in reproductive health? Immediate Benefits

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 News Release

    Les services de santé sexuelle et reproductive sont insuffisants dans les pays en développement

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Fact Sheet

    La inversión en salud sexual y reproductiva en América Latina y el Caribe

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • March 2016 Infographic

    ¿Por qué invertir en salud sexual y reproductiva en el mundo en desarrollo?

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Report

    Haciendo cuentas: los costos y beneficios de invertir en servicios de salud sexual y reproductiva 2014

    Susheela Singh, Jacqueline E. Darroch and Lori S. Ashford

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • December 2014 News Release

    Sexual and Reproductive Health Services Fall Far Short of Needs in Developing Regions

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Infographic

    Why invest in sexual and reproductive health in Sub-Saharan Africa?

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy

Pages

  • « first
  • ‹ previous
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • next ›
  • last »
Explore the Data Center

Hear From An Expert

The evidence strongly indicates that providing women with effective new tools to simultaneously prevent unwanted pregnancy as well as protect against STIs and HIV is essential. However, just developing these methods is not enough. They need to be designed and marketed in a way that meets the needs and respects the rights of women and their partners. Ultimately, multipurpose prevention technologies (MPTs) will be viable options only if women actually use them

Heather D. Boonstra

Vice President for Public Policy

Select a country profile

Sign up for Guttmacher updates

Get the latest research and policy analyses on sexual and reproductive health and rights around the world.

Subscribe
Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2022 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get our updates & newsletters